ECRI’s passion for safe, effective, and efficient care is ingrained into the fabric of who the company is. For more than 50 years, the people of ECRI have been unyielding in their work to protect patients from unsafe and ineffective medical technologies and practices. Now, with the affiliation of the Institute for Safe Medication Practices (ISMP), ECRI has created one of the largest healthcare quality and safety entities in the world. Part of ISMP’s mission is to work with the FDA and pharmaceutical companies to help them avoid medication safety problems. ISMP’s wholly-owned for-profit subsidiary, Medication Safety Board (MSB), works directly with the pharmaceutical industry to identify and help prevent errors related to packaging and labeling, further assuring patient safety.
ECRI and ISMP are proud to serve the healthcare industry, from providers and insurers to government agencies, and medical associations. The company is driven to always dig deeper in pursuit of advance effective, evidence-based healthcare globally – it’s what makes ECRI both unique and a trusted voice in healthcare.
How is ECRI contributing to the future of healthcare?
One significant change is the transition of healthcare delivery from acute care hospitals to outpatient ambulatory settings and even into the home. This trend has been underway for a number of years, but the COVID-19 pandemic has accelerated this seismic shift. Telehealth and remote care are skyrocketing. Treatments and procedures take place in outpatient ambulatory care centers and clinics. Patients are recovering or receiving treatments in their homes. ECRI and ISMP stand in the gap as these transformations in healthcare occur – providing awareness of risks in an effort to assure patient safety.